| |
| Magyar Aneszteziológiai és Intenzív Terápiás Társaság |
|
| A MAITT Echocardiographiás Szekciójának ülése |
 Rendezvény kezdete: 2012.04.13. | Rendezvény vége: 2012.04.13. |
| Helyszín: Budapest, IX., Haller u. 29., Gottsegen György Országos Kardiológiai Intézet II. emeleti tanácsterme |
A MAITT Echocardiographiás Szekciója 2012. április 13-án 14 órakor tartja következő ülését, amelyre szeretettel meghívjuk Önt és munkatársait.
1. A tudományos ülés témája a jobb kamraelégtelenség és a műthetőség.
a. A pulmonális hipertónia és jobb kamra elégtelenség klinikuma
Dr. Babik Barna Szeged
b. Jobb kamra funkció megítélés a műthetőség szempontjából
Dr. Szudi László Budapest
c. Jobb kamra funkció congenitális vitiumokban
Dr. Temesvári András Budapest
2. Vezetőség választás.
Farkasfalvi Klára sajnálatos halálával új vezetőségi tagot kell választanunk.
A tudományos ülés helye: Gottsegen György Országos Kardiológiai Intézet II. emeleti tanácsterme. Cím: Budapest, IX. kerület Haller utca 29.
Dr. Szudi László
MAITT Echocardiográphiás Szekció Elnöke |
|
|
 |
| |
| Magyar Hypertonia Társaság |
|
| 19th Scientific Meeting of the ESH |
| Rendezvény kezdete: 2009.06.12. | Rendezvény vége: 2009.06.16. |
| Helyszín: Italy, Milan, via Gattamelata 2, Milan Convention Centre |
| A rendezvény Web oldala: http://www.eshmilan.org/ |
The scientific programme will continue the tradition of the many ESH meetings which have been held in the past. That is, a large portion of the programme will be devoted to oral and poster presentations which will be selected from the abstracts submitted by the participants, based on the assessment of several expert reviewers per abstract.
The programme will also include:
1) State-of-the-Art Lectures, Debates and Round Tables to complement presentations of original research with views of topics of basic and clinical interest from worldwide authorities in hypertension
2) Satellite Symposia organized by Drug Industry, which will be held in the days before, after and during (evening) the main meeting, allow more specific information on new treatments of hypertension and related cardiovascular diseases to be presented and discussed
3) Breakfast Workshops and scientific sessions organized by the Working Groups of ESH and presentations, in separate sessions, of the research activities of Young European investigators and
4) Teaching Sessions focused on aspects of more practical interest and on clinical cases aimed more specifically at physicians interested in becoming European Hypertension Specialists. Several How-to Sessions aimed at presenting and discussing practical aspects of methods to be used in the initial and subsequent management of hypertension and cardiovascular risk will also be included in the programme, using a format that will allow a limited number of attendees to interact with the expert. |
|
|
|
| |
| Magyar Hypertonia Társaság |
|
| 19th European Meeting on Hypertension |
| Rendezvény kezdete: 2009.06.12. | Rendezvény vége: 2009.06.16. |
| Munkahely neve: AIM Group - AIM Congress |
| Címe: Via Flaminia 1068, 00189 Rome (Italy) |
| Tel: +39 (06) 330531 |
| Fax: +39 (06) 33053249 |
| E-mail: esh2009@aimgroup.it |
| Helyszín: Italy, Milan, via Gattamelata 2., Milan Convention Centre |
| A rendezvény Web oldala: http://www.esh2009.com/ |
Like previous meetings, there is a high quality scientific program related to research in Basic and Clinic areas in Hypertension, State-of-the-Art Lectures, Satellite Symposia, Breakfast Workshops, Working Groups sessions and credits for qualifying as Hypertension Specialists of the European Society of Hypertension.
Hypertension has become the number one cause of death in the world according to a WHO supported investigation. Despite the many scientific advances of the past few decades, much work remains to be done. Although we all do our best to reduce coronary heart disease, stroke, heart failure and cardiovascular complications, diabetes and obesity continue to increase worldwide. Primary and secondary prevention of cardiovascular diseases require a global approach of the cardiovascular risk, and an in-depth understanding of the mechanisms of hypertension. |
|
|
|
